As a service to our members, prescribers, and pharmacy partners, nirvanaHealth is providing information regarding the latest news in drug therapy, including information about recently approved drugs, new generics, changes in drug therapy indications, and changes to clinical treatment guidelines. Additionally, updates to the National Drug Formulary are provided here. Keep a pulse on the latest drug industry news and more with the following clinical notices.
| Affected Product(s) | Notice Type | Date of Notice | |||||
|---|---|---|---|---|---|---|---|
| Multiple | Formulary Update | 7/1/2023 | View PDF | ||||
| Plasma-Lyte 148 (multiple electrolytes Injection Type 1, USP, pH 5.5) | First Time Generic Approval | 6/29/2023 | View PDF | ||||
| Talzenna® (talazoparib) | Clinical Update | 6/20/2023 | View PDF | ||||
| Columvi™ (glofitamab-gxbm) | New Drug Approval | 6/15/2023 | View PDF | ||||
| Plasma-Lyte A (multiple electrolytes Injection) | First Time Generic Approval | 6/8/2023 | View PDF | ||||
| Prezista® (darunavir ethanolate) | First Time Generic Approval | 6/3/2023 | View PDF | ||||
| Brixadi™ (buprenorphine) | New Drug Approval | 5/23/2023 | View PDF | ||||
| Miebo™ (perfluorohexyloctane) | New Drug Approval | 5/18/2023 | View PDF | ||||
| Celontin® (methsuximide) | First Time Generic Approval | 5/1/2023 | View PDF | ||||
| Zejula® (niraparib) | Clinical Update | 4/26/2023 | View PDF | ||||
| Multiple | Formulary Update | 4/1/2023 | View PDF | ||||
| Pylera® (bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride) | First Time Generic Approval | 3/6/2023 | View PDF | ||||
| Altuviiio™ (antihemophilic factor (recombinant) | New Drug Approval | 2/23/2023 | View PDF | ||||
| Syfovre™ (pegcetacoplan) | New Drug Approval | 2/17/2023 | View PDF | ||||
| Filspari™ (sparsentan) | New Drug Approval | 2/17/2023 | View PDF | ||||
| Lamzede® (velmanase alfa-tycv) | New Drug Approval | 2/16/2023 | View PDF | ||||
| Atorvaliq® (atorvastatin calcium) | Clinical Update | 2/1/2023 | View PDF | ||||
| Orserdu™ (elacestrant) | New Drug Approval | 1/27/2023 | View PDF | ||||
| Jaypirca™ (pirtobrutinib) | New Drug Approval | 1/27/2023 | View PDF | ||||
| Briumvi™ (ublituximab-xiiy) | New Drug Approval | 12/28/2022 | View PDF | ||||
| Sunlenca® (lenacapavir) | New Drug Approval | 12/22/2022 | View PDF | ||||
| Lunsumio™ (mosunetuzumab-axgb) | New Drug Approval | 12/22/2022 | View PDF | ||||
| Krazati™ (adagrasib) | New Drug Approval | 12/12/2022 | View PDF | ||||
| Hetlioz® (tasimelteon) | First Time Generic Approval | 12/12/2022 | View PDF | ||||
| Tascenso ODT™ (fingolimod) | Clinical Update | 12/9/2022 | View PDF | ||||
| Vivimusta™ (bendamustine hydrochloride injection) | New Drug Approval | 12/7/2022 | View PDF | ||||
| Rezlidhia™ (olutasidenib) | New Drug Approval | 12/1/2022 | View PDF | ||||
| Multiple | Formulary Update | 12/1/2022 | View PDF | ||||
| Rebyota™ (fecal microbiota, live – jslm) | New Drug Approval | 11/30/2022 | View PDF | ||||
| Hemgenix® (etranacogene dezaparvovec-drlb) | New Drug Approval | 11/22/2022 | View PDF | ||||
| Tzield™ (teplizumab-mzwv) | New Drug Approval | 11/17/2022 | View PDF | ||||
| Humalog Tempo Pen™ (insulin lispro injection) | Clinical Update | 11/17/2022 | View PDF | ||||
| Fotolyn™ (pralatrexate) | First Time Generic Approval | 11/15/2022 | View PDF | ||||
| Elahere™ (mirvetuximab soravtansine-gynx) | New Drug Approval | 11/14/2022 | View PDF | ||||
| Tecvayli™ (teclistamab-cqyv) | New Drug Approval | 10/25/2022 | View PDF | ||||
| Imjudo® (tremelimumab-actl) | New Drug Approval | 10/21/2022 | View PDF | ||||
| Lyumjev Tempo Pen® (insulin lispro-aabc) | Clinical Update | 10/14/2022 | View PDF | ||||
| Turalio® (pexidartinib) | Clinica Update | 10/14/2022 | Daliresp® (roflumilast) | First Time Generic Approval | 10/13/2022 | View PDF | |
| Furoscix® (furosemide) | New Drug Approval | 10/7/2022 | View PDF | ||||
| Lytgobi® (futibatinib) | New Drug Approval | 9/30/2022 | View PDF | ||||
| Relyvrio™ (sodium phenylbutyrate and taurursodiol) | New Drug Approval | 9/29/2022 | View PDF | ||||
| Vegzelma® (bevacizumab-adcd) | New Drug Approval | 9/27/2022 | View PDF | ||||
| Elucirem™ (gadopiclenol) | New Drug Approval | 9/21/2022 | View PDF | ||||
| Skysona® (elivaldogene autotemcel) | New Drug Approval | 9/16/2022 | View PDF | ||||
| Terlivaz® (terlipressin) | New Drug Approval | 9/14/2022 | View PDF | ||||
| Nexavar® (sorafenib tosylate) | First Time Generic Approval | 9/10/2022 | View PDF | ||||
| Sotyktu™ (deucravacitinib) | New Drug Approval | 9/9/2022 | View PDF | ||||
| Rolvedon™ (eflapegrastim-xnst) | New Drug Approval | 9/9/2022 | View PDF | ||||
| Daxxify™ (daxibotulinumtoxinA-lanm) | New Drug Approval | 9/7/2022 | View PDF | ||||
| Orkambi® (lumacaftor and ivacaftor) | Clinical Update | 9/2/2022 | View PDF | ||||
| Spevigo® (spesolimab-sbzo) | New Drug Approval | 9/1/2022 | View PDF | ||||
| Stimufend® (pegfilgrastim-fpgk) | New Drug Approval | 9/1/2022 | View PDF | ||||
| Imbruvica® (ibrutinib) | Clinical Update | 8/24/2022 | View PDF | ||||
| Auvelity™ (dextromethorphan hydrobromide and bupropion hydrochloride) | New Drug Approval | 8/18/2022 | View PDF | ||||
| Zynteglo® (betibeglogene autotemcel) | New Drug Approval | 8/17/2022 | View PDF | ||||
| Cimerli™ (ranibizumab-eqrn) | New Drug Approval | 8/2/2022 | View PDF | ||||
| Zoryve™ (roflumilast) | New Drug Approval | 7/29/2022 | View PDF | ||||
| Kyzatrex™ (testosterone undecanoate) | New Drug Approval | 7/27/2022 | View PDF | ||||
| Zonisade™ (zonisamide) | New Drug Approval | 7/15/2022 | View PDF | ||||
| Bludigo™ (indigotindisulfonate sodium) | New Drug Approval | 7/8/2022 | View PDF | ||||
| Tresiba® (insulin degludec) | First Time Generic Approval | 7/1/2022 | View PDF | ||||
| Dyanavel® XR (amphetamine) | Clinical Update | 7/1/2022 | View PDF | ||||
| venlafaxine besylate (venlafaxine besylate) | Clinical Update | 6/29/2022 | View PDF | ||||
| Pheburane® (sodium phenylbutyrate) | New Drug Approval | 6/17/2022 | View PDF | ||||
| Tadliq® (tadalafil) | Clinical Update | 6/17/2022 | View PDF | ||||
| Skyrizi® (risankizumab-rzaa) | Clinical Update | 6/16/2022 | View PDF | ||||
| Amvuttra™ (vutrisiran) | New Drug Approval | 6/13/2022 | View PDF | ||||
| Priorix (measles, mumps and rubella vaccine, live) | New Drug Approval | 6/6/2022 | View PDF | ||||
| Fylnetra® (pegfilgrastim-pbbk) | New Drug Approval | 5/26/2022 | View PDF | ||||
| fluticasone furoate and vilanterol (fluticasone furoate and vilanterol) | First Time Generic Approval | 5/25/2022 | View PDF | ||||
| Alimta® (pemetrexed disodium) | First Time Generic Approval | 5/25/2022 | View PDF | ||||
| fluticasone propionate (fluticasone propionate) | First Time Generic Approval | 5/24/2022 | View PDF | ||||
| Vtama® (tapinarof) | New Drug Approval | 5/23/2022 | View PDF | ||||
| Tyvaso DPI™ (treprostinil) | New Drug Approval | 5/23/2022 | View PDF | ||||
| Tpoxx® (tecovirimat) | New Drug Approval | 5/18/2022 | View PDF | ||||
| carmustine (carmustine) | Clinical Update | 5/16/2022 | View PDF | ||||
| Mounjaro™ (tirzepatide) | New Drug Approval | 5/13/2022 | View PDF | ||||
| Radicava®, Radicava® ORS (edaravone) | New Drug Approval | 5/12/2022 | View PDF | ||||
| Apriso™ (mesalamine) | First Time Generic Approval | 5/11/2022 | View PDF | ||||
| Pennsaid (diclofenac sodium) | First Time Generic Approval | 5/6/2022 | View PDF | ||||
| Voquezna™ Dual Pack™ (amoxicillin; vonoprazan fumarate) | New Drug Approval | 5/3/2022 | View PDF | ||||
| Voquezna™ Triple Pack™ (amoxicillin; clarithromycin; vonoprazan fumarate) | New Drug Approval | 5/3/2022 | View PDF | ||||
| insulin glargine (insulin glargine) | First Time Generic Approval | 5/2/2022 | View PDF | ||||
| bortezomib (bortezomib) | Clinical Update | 5/2/2022 | View PDF | ||||
| Camzyos™ (mavacamten) | New Drug Approval | 4/28/2022 | View PDF | ||||
| Targretin® (bexarotene) | First Time Generic Approval | 4/27/2022 | View PDF | ||||
| Vivjoa™ (oteseconazole) | New Drug Approval | 4/26/2022 | View PDF | ||||
| Caplyta® (lumateperone) | Clinical Update | 4/26/2022 | View PDF | ||||
| Epsolay® (benzoyl peroxide) | New Drug Approval | 4/22/2022 | View PDF | ||||
| Alymsys® (bevacizumab-maly) | New Drug Approval | 4/13/2022 | View PDF | ||||
| Adlarity® (donepezil hydrochloride) | New Drug Approval | 4/11/2022 | View PDF | ||||
| Vijoice® (alpelisib) | New Drug Approval | 4/5/2022 | View PDF | ||||
| Igalmi™ (dexmedetomidine) | New Drug Approval | 4/5/2022 | View PDF | ||||
| Multiple | Formulary Update | 4/1/2022 | View PDF | ||||
| Triumeq PD (abacavir, dolutegravir, and lamivudine) | New Drug Approval | 3/30/2022 | View PDF | ||||
| Ozempic® (semaglutide) | New Drug Approval | 3/28/2022 | View PDF | ||||
| Pluvicto™ (lutetium Lu 177 vipivotide tetraxetan) | New Drug Approval | 3/23/2022 | View PDF | ||||
| Xelstrym™ (dextroamphetamine) | New Drug Approval | 3/22/2022 | View PDF | ||||
| Opdualag™ (nivolumab and relatlimab-rmbw) | New Drug Approval | 3/18/2022 | View PDF | ||||
| Rinvoq® (upadacitinib) | Clinical Update | 3/16/2022 | View PDF | ||||
| Daytrana® (methylphenidate) | First Time Generic Approval | 3/14/2022 | View PDF | ||||
| Mayzent® (siponimod fumaric acid) | Clinical Update | 3/1/2022 | View PDF | ||||
| Vonjo™ (pacritinib) | New Drug Approval | 2/28/2022 | View PDF | ||||
| Carvykti™ (ciltacabtagene autoleucel) | New Drug Approval | 2/28/2022 | View PDF | ||||
| Aspruzyo Sprinkle™ (ranolazine) | New Drug Approval | 2/28/2022 | View PDF | ||||
| Releuko® (filgrastim-ayow) | New Drug Approval | 2/25/2022 | View PDF | ||||
| Norliqva® (amlodipine) | New Drug Approval | 2/24/2022 | View PDF | ||||
| Apokyn® (apomorphine hydrochloride) | First Time Generic Approval | 2/23/2022 | View PDF | ||||
| Hyftor™ (sirolimus) | New Drug Approval | 2/22/2022 | View PDF | ||||
| Pyrukynd® (mitapivat) | New Drug Approval | 2/17/2022 | View PDF | ||||
| Selzentry (maraviroc) | First Time Generic Approval | 2/7/2022 | View PDF | ||||
| Fleqsuvy™ (baclofen oral suspension) | New Drug Approval | 2/4/2022 | View PDF | ||||
| Enjaymo™ (sutimlimab-jome) | New Drug Approval | 2/4/2022 | View PDF | ||||
| Restasis® (cyclosporine) | First Time Generic Approval | 2/2/2022 | View PDF | ||||
| Citalopram (citalopram) | Clinical Update | 1/31/2022 | View PDF | ||||
| Moderna COVID-19 Booster (COVID-19 vaccine, mRNA, cx-024414, LNP-S (Moderna)/PF) | Clinical Update | 1/31/2022 | View PDF | ||||
| Esbrietè® (pirfenidone) | First Time Generic Approval | 1/25/2022 | View PDF | ||||
| Nucala® (mepolizumab) | Clinical Update | 1/22/2022 | View PDF | ||||
| Noxafil® (posaconazole) | Clinical Update | 1/20/2022 | View PDF | ||||
| Cibinqo™ (abrocitinib) | New Drug Approval | 1/14/2022 | View PDF | ||||
| Rinvoq® (upadacitinib) | Clinical Update | 1/14/2022 | View PDF | ||||
| Ryaltris™ (olopatadine hydrochloride and mometasone furoate monohydrate) | New Drug Approval | 1/13/2022 | View PDF | ||||
| BiDil® (isosorbide dinitrate and hydralazine hydrochloride) | First Time Generic Approval | 1/13/2022 | View PDF | ||||
| Viibryd™ (vilazodone hydrochloride) | First Time Generic Approval | 1/10/2022 | View PDF | ||||
| Quviviq™ (daridorexant) | New Drug Approval | 1/7/2022 | View PDF | ||||
| Descovy® (emtricitabine and tenofovir alafenamide) | Clincal Update | 1/7/2022 | View PDF | ||||
| Recorlev® (levoketoconazole) | New Drug Approval | 12/30/2021 | View PDF | ||||
| Adbry™ (tralokinumab-ldrm) | New Drug Approval | 12/27/2021 | View PDF | ||||
| Tascenso ODT™ (fingolimod) | New Drug Approval | 12/23/2021 | View PDF | ||||
| Narcon® (naloxone hydrochloride) | First Time Generic | 12/22/2021 | View PDF | ||||
| Apretude (cabotegravir) | New Drug Approval | 12/20/2021 | View PDF | ||||
| Rezvoglar™ (insulin glargine-aglr) | New Drug Approval | 12/17/2021 | View PDF | ||||
| Vyvgart™ (efgartigimod alfa-fcab) | New Drug Approval | 12/17/2021 | View PDF | ||||
| Tezspire™ (tezepelumab-ekko) | New Drug Approval | 12/17/2021 | View PDF | ||||
| Oxbryta (voxelator) | Clinical Update | 12/17/2021 | View PDF | ||||
| Dartisla ODT (glycopyrrolate) | New Drug Approval | 12/16/2021 | View PDF | ||||
| Tarpey™ (budesonide) | New Drug Approval | 12/15/2021 | View PDF | ||||
| AmBisome® (amphotericin b) | First Time Generic Approval | 12/14/2021 | View PDF | ||||
| Combigan® (brimonidine-timolol) | First Time Generic Approval | 12/13/2021 | View PDF | ||||
| Xarelto® (rivaroxaban) | Clinical Update | 12/12/2021 | View PDF | ||||
| Nuwiq® (antihemophilic factor (recombinant)) | Clinical Update | 12/12/2021 | View PDF | ||||
| Entadfi™ (finasteride and tadalafil) | New Drug Approval | 12/9/2021 | View PDF | ||||
| Evusheld™ (tixagevimab co-packaged with cilgavimab) | New Drug Approval | 12/8/2021 | View PDF | ||||
| Multiple | Formulary & Clinical Updates | 12/1/2021 | View PDF | ||||
| Prehevbrio™ (Hepatitis B Vaccine (Recombinant)) | New Drug Approval | 11/30/2021 | View PDF | ||||
| Livtencity™ (maribavir) | New Drug Approval | 11/23/2021 | View PDF | ||||
| Cystadane® (betaine) | First Time Generic Approval | 11/23/2021 | View PDF | ||||
| Lyvispah™ (baclofen) | New Drug Approval | 11/22/2021 | View PDF | ||||
| Fyarro™ (sirolimus albumin bound nanoparticles) | Clinical Update | 11/22/2021 | View PDF | ||||
| Voxzogo™ (vosoritide) | New Drug Approval | 11/19/2021 | View PDF | ||||
| nelarabine (nelarabine) | First Time Generic Approval | 11/17/2021 | View PDF | ||||
| Besremi® (ropeginterferon alfa-2b-njf) | New Drug Approval | 11/12/2021 | View PDF | ||||
| Dhivy® (carbidopa levodopa) | Clinical Update | 11/12/2021 | View PDF | ||||
| Eprontia™ (topiramate) | Clinical Update | 11/5/2021 | View PDF | ||||
| Scemblix® (asciminib) | New Drug Approval | 10/29/2021 | View PDF | ||||
| Vuity™ (pilocarpine hydrochloride) | New Drug Approval | 10/28/2021 | View PDF | ||||
| Xipere™ (triamcinolone acetonide) | New Drug Approval | 10/22/2021 | View PDF | ||||
| Gvoke™ (glucagon) | Clinical Update | 10/20/2021 | View PDF | ||||
| Dupixent® (dupilumab) | Clinical Update | 10/20/2021 | View PDF | ||||
| Carglumic acid (Carglumic acid) | First Time Generic Approval | 10/13/2021 | View PDF | ||||
| Tavneos™ (avacopan) | New Drug Approval | 10/7/2021 | View PDF | ||||
| infliximab (infliximab) | First Time Generic Approval | 10/5/2021 | View PDF | ||||
| Livmarli™ (maralixibat) | New Drug Approval | 9/29/2021 | View PDF | ||||
| Qulipta™ (atogepant) | New Drug Approval | 9/28/2021 | View PDF | ||||
| Opzelura (ruxolitinib) | New Drug Approval | 9/21/2021 | View PDF | ||||
| Talzenna® (talazoparib) | Clinical Update | 9/21/2021 | View PDF | ||||
| Tivdak™ (tisotumab vedotin-tftv) | New Drug Approval | 9/20/2021 | View PDF | ||||
| Exkivity™ (mobocertinib) | New Drug Approval | 9/15/2021 | View PDF | ||||
| hydroxychloroquine sulfate (Plaquenil®) | Clinical Update | 9/10/2021 | View PDF | ||||
| Nebivolol (nebivolol) | First Time Generic Approval | 9/9/2021 | View PDF | ||||
| paliperidone palmitate (Invega hafyera™) | Clinical Update | 8/30/2021 | View PDF | ||||
| Loreev XR® (lorazepam) | New Drug Approval | 8/27/2021 | View PDF | ||||
| Loreev XR® (lorazepam) | Clinical Update | 8/27/2021 | View PDF | ||||
| Skytrofa™ (lonapegsomatropin-tcgd) | Clinical Update | 8/25/2021 | View PDF | ||||
| Korsuva™ (difelikefalin acetate) | New Drug Approval | 8/23/2021 | View PDF | ||||
| Comirnaty® (covid-19 Vaccine, mRNA) | Clinical Update | 8/23/2021 | View PDF | ||||
| Sunitinib malate (sunitinib malate) | First Time Generic Approval | 8/16/2021 | View PDF | ||||
| Welireg™ (belzutifan) | New Drug Approval | 8/13/2021 | View PDF | ||||
| Enalapril maleate (enalapril maleate) | Clinical Update | 8/10/2021 | View PDF | ||||
| difluprednate (difluprednate) | First Time Generic Approval | 8/9/2021 | View PDF | ||||
| Cuvposa® (glycopyrrolate) | First Time Generic Approval | 8/9/2021 | View PDF | ||||
| Nexviazyme™ (avalglucosidase alfa-ngpt) | New Drug Approval | 8/6/2021 | View PDF | ||||
| Revlimid® (lenalidomide) | First Time Generic Approval | 8/5/2021 | View PDF | ||||
| Herceptin® (trastuzumab) | Clinical Update | 8/5/2021 | View PDF | ||||
| Tembexa® (brincidofovir) | New Drug Approval | 8/3/2021 | View PDF | ||||
| Buprenorphine Hydrochloride (buprenorphine hydrochloride) | First Time Generic Approval | 8/3/2021 | View PDF | ||||
| Saphnelo™ (anifrolumab-fnia) | New Drug Approval | 7/30/2021 | View PDF | ||||
| Uptravi® (selexipag) | Clinical Update | 7/29/2021 | View PDF | ||||
| Insulin glargine (insulin glargine-yfgn) | First Time Generic | 7/28/2021 | View PDF | ||||
| Semglee® (insulin glargine-yfgn) | Clinical Update | 7/28/2021 | View PDF | ||||
| Twyneo® (tretinoin and benzoyl peroxide) | New Drug Approval | 7/26/2021 | View PDF | ||||
| Bylvay™ (odevixibat) | New Drug Approval | 7/20/2021 | View PDF | ||||
| Rezurock™ (belumosudil) | New Drug Approval | 7/16/2021 | View PDF | ||||
| Vaxneuvance™ (pneumococcal 15-valent Conjugate Vaccine) | Clinical Update | 7/16/2021 | View PDF | ||||
| Chantix™ (varenicline) | First Time Generic Approval | 7/15/2021 | View PDF | ||||
| Feraheme® (ferumoxytol) | First Time Generic Approval | 7/15/2021 | View PDF | ||||
| Kerendia® (finerenone) | New Drug Approval | 7/14/2021 | View PDF | ||||
| Multiple | Formulary & Clinical Update | 7/7/2021 | View PDF | ||||
| Verkazia® (cyclosporine ophthalmic emulsion) | New Drug Approval | 6/23/2021 | View PDF | ||||
| Perforomist® (formoterol fumarate) | First Time Generic | 6/22/2021 | View PDF | ||||
| Pradaxa® (dabigatran etexilate) | Clinical Update | 6/21/2021 | View PDF | ||||
| Ayvakit™ (avapritinib) | Clinical Update | 6/16/2021 | View PDF | ||||
| Soaanz® (torsemide) | New Drug Approval | 6/14/2021 | View PDF | ||||
| Etravirine (etravirine) | First Time Generic Approval | 6/14/2021 | View PDF | ||||
| Mavyret® (glecaprevir and pibrentasvir) | Clinical Update | 6/10/2021 | View PDF | ||||
| Aduhelm™ (aducanumab-avwa) | New Drug Approval | 6/7/2021 | View PDF | ||||
| Sajazir™ (icatibant) | Clinical Update | 6/3/2021 | View PDF | ||||
| sotrovimab | New Drug Approval | 6/2/2021 | View PDF | ||||
| Lumakras™ (sotorasib) | New Drug Approval | 6/2/2021 | View PDF | ||||
| Pylarify® (piflufolastat F 18) | New Drug Approval | 6/2/2021 | View PDF | ||||
| Truseltiq™ (infigratinib) | New Drug Approval | 6/2/2021 | View PDF | ||||
| Bepreve® (bepotastine besilate) | First Time Generic Approval | 6/2/2021 | View PDF | ||||
| Myfembree® (relugolix, estradiol, and norethindrone acetate) | New Drug Approval | 6/1/2021 | View PDF | ||||
| Banzel® (rufinamide) | Clinical Update | 6/1/2021 | View PDF | ||||
| Lybalvi™ (olanzapine and samidorphan) | New Drug Approval | 5/28/2021 | View PDF | ||||
| Camcevi™ (leuprolide) | New Drug Approval | 5/25/2021 | View PDF | ||||
| Rybrevant™ (amivantamab-vmjw) | New Drug Approval | 5/21/2021 | View PDF | ||||
| Empaveli™ (pegcetacoplan) | New Drug Approval | 5/14/2021 | View PDF | ||||
| Multiple | Formulary and Clinical Updates | 5/14/2021 | View PDF | ||||
| Zynrelef™ (bupivacaine and meloxicam) | New Drug Approval | 5/12/2021 | View PDF | ||||
| Tritocin (triamcinolone-acetonide) | Clinical Update | 5/3/2021 | View PDF | ||||
| DesRx (desonide) | Clinical Update | 5/3/2021 | View PDF | ||||
| Thiola® (tiopronin) | First Time Generic | 4/26/2021 | View PDF | ||||
| Zynlonta™ (loncastuximab tesirine-lpyl) | New Drug Approval | 4/23/2021 | View PDF | ||||
| Jemperli® (dostarlimab-gxly) | New Drug Approval | 4/22/2021 | View PDF | ||||
| Nextstellis® (drospirenone and estetrol) | New Drug Approval | 4/15/2021 | View PDF | ||||
| Xpovio® (selinexor) | Clinical Update | 4/15/2021 | View PDF | ||||
| Lyrica® CR (pregabalin) | First Time Generic Approval | 4/13/2021 | View PDF | ||||
| Qelbree™ (viloxazine) | New Drug Approval | 4/2/2021 | View PDF | ||||
| Abecma® (idecabtagene vicleucel) | New Drug Approval | 3/26/2021 | View PDF | ||||
| Myrbetriq® (mirabegron) | Clinical Update | 3/25/2021 | View PDF | ||||
| Roszet® (rosuvastatin and ezetimibe) | New Drug Approval | 3/23/2021 | View PDF | ||||
| Rosuvastatin and ezetimibe (rosuvastatin and ezetimibe) | First Time Generic | 3/23/2021 | View PDF | ||||
| Zegalogue® (dasiglucagon) | New Drug Approval | 3/22/2021 | View PDF | ||||
| Kimyrsa™ (oritavancin diphosphate) | Clinical Update | 3/21/2021 | View PDF | ||||
| Ponvory™ (ponesimod) | New Drug Approval | 3/18/2021 | View PDF | ||||
| Xofluza (baloxavir-marboxil) | Clinical Update | 3/18/2021 | View PDF | ||||
| Vimpat® (lacosamide) | First Time Generic Approval | 3/12/2021 | View PDF | ||||
| Fotivda® (tivozanib hydrochloride) | New Drug Approval | 3/10/2021 | View PDF | ||||
| Hysingla ER® (hydrocodone bitartrate) | First Time Generic Approval | 3/1/2021 | View PDF | ||||
| Pepaxto® (melphalan flufenamide; melflufen) | New Drug Approval | 2/26/2021 | View PDF | ||||
| Nulibry™ (fosdenopterin) | New Drug Approval | 2/26/2021 | View PDF | ||||
| Amondys 45™ (casimersen) | New Drug Approval | 2/25/2021 | View PDF | ||||
| Zafemy™ (norelgestromin and ethinyl estradiol transdermal system) | Clinical Update | 2/25/2021 | View PDF | ||||
| Northera® (droxidopa) | First Time Generic Approval | 2/18/2021 | View PDF | ||||
| Cosela™ (trilaciclib) | New Drug Approval | 2/12/2021 | View PDF | ||||
| Evkeeza™ (evinacumab-dgnb) | New Drug Approval | 2/11/2021 | View PDF | ||||
| bamlanivimab and etesevimab | New Drug Approval | 2/9/2021 | View PDF | ||||
| Ukoniq™ (umbralisib) | New Drug Approval | 2/5/2021 | View PDF | ||||
| Breyanzi® (lisocabtagene maraleuce) | New Drug Approval | 2/5/2021 | View PDF | ||||
| Tepmetko® (tepotinib) | New Drug Approval | 2/3/2021 | View PDF | ||||
| Plegridy® (peginterferon beta-1a) | Clinical Update | 1/29/2021 | View PDF | ||||
| Lupkynis™ (voclosporin) | New Drug Approval | 1/22/2021 | View PDF | ||||
| Zomig® (zolmitriptan) | First Time Generic Approval | 1/22/2021 | View PDF | ||||
| Vocabria® (cabotegravir) | New Drug Approval | 1/21/2021 | View PDF | ||||
| Cabenuva® ( cabotegravir and rilpivirine) | New Drug Approval | 1/21/2021 | View PDF | ||||
| Verquvo™ (vericiguat) | New Drug Approval | 1/19/2021 | View PDF | ||||
| Flolan®(epoprostenol) | New Drug Approval | 1/15/2021 | View PDF | ||||
| TirosintSo (levothyroxine sodium) | Clinical Update | 1/13/2021 | View PDF | ||||
| Lyleq™ (norethindrone) | Clinical Update | 1/8/2021 | View PDF | ||||
| Gemtesa® (vibegron) | New Drug Approval | 12/23/2020 | View PDF | ||||
| Multiple | Formulary & Clinical Updates | 12/23/2020 | View PDF | ||||
| Entereg® (alvimopan) | First Time Generic Approval | 12/19/2020 | View PDF | ||||
| Orgovyx™ (relugolix) | New Drug Approval | 12/18/2020 | View PDF | ||||
| Merzee™ (norethindrone acetate/ethinyl estradiol/ferrous fumarate) | Clinical Update | 12/18/2020 | View PDF | ||||
| Riabni™ (rituximab-arrx) | New Drug Approval | 12/17/2020 | View PDF | ||||
| Danyelza® (naxitamab-gqgk) | New Drug Approval | 12/16/2020 | View PDF | ||||
| Margenza™ (margetuximab-cmkb) | New Drug Approval | 12/16/2020 | View PDF | ||||
| Klisyri® (tirbanibulin) | New Drug Approval | 12/14/2020 | View PDF | ||||
| Nymyo® (norgestimate and ethinyl estradiol) | Clinical Update | 12/11/2020 | View PDF | ||||
| Saphris® (asenapine maleate) | First Time Generic Approval | 12/10/2020 | View PDF | ||||
| Orladeyo® (berotralstat) | New Drug Approval | 12/3/2020 | View PDF | ||||
| Hetlioz LQ® (tasimelteon) | Clinical Update | 12/1/2020 | View PDF | ||||
| Amitiza (lubiprostone) | First Time Generic Approval | 11/30/2020 | View PDF | ||||
| Thyquidity® levothyroxine sodium | Clinical Update | 11/30/2020 | View PDF | ||||
| Trazimera™ (trastuzumab-qyyp) | Clinical Update | 11/30/2020 | View PDF | ||||
| Alinia® (nitazoxanide) | First Time Generic Approval | 11/27/2020 | View PDF | ||||
| Azopt® (brinzolamide) | First Time Generic Approval | 11/27/2020 | View PDF | ||||
| Imcivree® (setmelanotide) | New Drug Approval | 11/25/2020 | View PDF | ||||
| Oxlumo™ (lumasiran) | New Drug Approval | 11/23/2020 | View PDF | ||||
| REGN-COV2 (imdevimab) | New Drug Approval | 11/21/2020 | View PDF | ||||
| REGN-COV2 (casirivimab) | New Drug Approval | 11/21/2020 | View PDF | ||||
| Zokinvy™ (lonafarnib) | New Drug Approval | 11/20/2020 | View PDF | ||||
| moxifloxacin hydrochloride | Clinical Update | 11/17/2020 | View PDF | ||||
| Zovia® 1/35 (ethynodiol diacetate and ethinyl estradiol) | Clinical Update | 11/13/2020 | View PDF | ||||
| Sutab® (magnesium sulfate, sodium sulfate, potassium chloride) | New Drug Approval | 11/10/2020 | View PDF | ||||
| bamlanivimab | New Drug Approval | 11/9/2020 | View PDF | ||||
| Taytulla® (gemmily) | Clinical Update | 11/9/2020 | View PDF | ||||
| Bronchitol® (mannitol) | New Drug Approval | 10/30/2020 | View PDF | ||||
| Tirosint® (levothyroxine) | Clinical Update | 10/28/2020 | View PDF | ||||
| Eysuvis™ (loteprednol etabonate) | Clinical Update | 10/26/2020 | View PDF | ||||
| Veklury® (remdesivir) | New Drug Approval | 10/22/2020 | View PDF | ||||
| Dolishale™ (Levonorgestrel and ethinyl estradiol) | Clinical Update | 10/22/2020 | View PDF | ||||
| Jynarque®(Tolvaptan) | Clinical Update | 10/15/2020 | View PDF | ||||
| Kerydin® (tavaborole topical solution, 5%) | First Time Generic Approval | 10/13/2020 | View PDF | ||||
| Ultomiris® (ravulizumab-cwvz) | Clinical Update | 10/9/2020 | View PDF | ||||
| Monurol® (fosfomycin tromethamine) | First Time Generic Approval | 10/6/2020 | View PDF | ||||
| Multiple | Formulary & Clinical Updates | 10/1/2020 | View PDF | ||||
| Tykerb® (lapatinib) | First Time Generic Approval | 9/29/2020 | View PDF | ||||
| Alkindi® Sprinkle (hydrocortisone) | Clinical Update | 9/29/2020 | View PDF | ||||
| Xeljanz® (tofacitinib) | Clinical Update | 9/28/2020 | View PDF | ||||
| ArmonAir® Digihaler™ (fluticasone propionate) | Clinical Update | 9/18/2020 | View PDF | ||||
| Zorvolex®(diclofenac submicronized) | Clinical Update | 9/16/2020 | View PDF | ||||
| Trelegy Ellipta® (fluticasone furoate/umeclidinium/vilanterol) | Clinical Update | 9/9/2020 | View PDF | ||||
| Gavreto® (pralsetinib) | New Drug Approval | 9/4/2020 | View PDF | ||||
| Detectnet™ (copper cu 64 dotatate) | New Drug Approval | 9/3/2020 | View PDF | ||||
| Qdolo® (tramadol hydrochloride) | Clinical Update | 9/1/2020 | View PDF | ||||
| Onureg (azacitidine) | Clinical Update | 9/1/2020 | View PDF | ||||
| Lyllana™ (estradiol) | Clinical Update | 8/27/2020 | View PDF | ||||
| Winlevi®(clascoterone) | New Drug Approval | 8/26/2020 | View PDF | ||||
| Abraxane® (paclitaxel-protein bound) | First Time Generic Approval | 8/23/2020 | View PDF | ||||
| Kesimpta Pen (ofatumumab) | Clinical Update | 8/20/2020 | View PDF | ||||
| Cystadrops® (Cysteamine ophthalmic solution) | Clinical Update | 8/19/2020 | View PDF | ||||
| Tecfidera (dimethyl fumarate capsule) | First Time Generic Approval | 8/17/2020 | View PDF | ||||
| ENSPRYNG™ (satralizumab-mwge) | New Drug Approval | 8/14/2020 | View PDF | ||||
| VILTEPSO™ (Viltolarsen) | New Drug Approval | 8/12/2020 | View PDF | ||||
| Multiple | Formulary Update | 8/11/2020 | View PDF | ||||
| Olinvyk® oliceridine | New Drug Approval | 8/10/2020 | View PDF | ||||
| EVRYSDI™ (risdiplam) | New Drug Approval | 8/7/2020 | View PDF | ||||
| Lampit (nifurtimox) | New Drug Approval | 8/6/2020 | View PDF | ||||
| Dovato (dolutegravir and lamivudine) Tablets | Clinical Update | 8/6/2020 | View PDF | ||||
| BLENREP (belantamab mafodotin-blmf) | New Drug Approval | 8/5/2020 | View PDF | ||||
| Xtandi® (enzalutamide) | Clinical Update | 8/4/2020 | View PDF | ||||
| Monjuvi® (tafasitamab-cxix) | New Drug Approval | 7/31/2020 | View PDF | ||||
| Spravato (esketamine) Nasal Spray | Clinical Update | 7/31/2020 | View PDF | ||||
| Epidiolex (cannabidiol) Oral Solution | Clinical Update | 7/31/2020 | View PDF | ||||
| Tecentriq (atezolizumab) Injection | Clinical Update | 7/30/2020 | View PDF | ||||
| TECARTUS™ (brexucabtagene autoleucel) | New Drug Approval | 7/24/2020 | View PDF | ||||
| DEMSER® (metyrosine) | First Time Generic Approval | 7/24/2020 | View PDF | ||||
| Breztri Aerosphere™ (glycopyrrolate and formoterol fumarate) | New Drug Approval | 7/23/2020 | View PDF | ||||
| Narcan; Evzio (naloxone) | Clinical Update | 7/23/2020 | View PDF | ||||
| Xywav™ (calcium, magnesium, potassium, and sodium oxybates) | New Drug Approval | 7/21/2020 | View PDF | ||||
| Wynzora® (calcipotriene and betamethasone dipropionate) | Clinical Update | 7/20/2020 | View PDF | ||||
| Qutenza (capsaicin) Transdermal Patch | Clinical Update | 7/17/2020 | View PDF | ||||
| Jadenu® Sprinkle (deferasirox) | First Time Generic Approval | 7/14/2020 | View PDF | ||||
| Tremfya (guselkumab) Injection | Clinical Update | 7/13/2020 | View PDF | ||||
| UPNEEQ (oxymetazoline hydrochloride ophthalmic solution) | New Drug Approval | 7/8/2020 | View PDF | ||||
| Dysport (abobotulinumtoxinA) Injection | Clinical Update | 7/8/2020 | View PDF | ||||
| Botox (onabotulinumtoxinA) Injection | Clinical Update | 7/8/2020 | View PDF | ||||
| INQOVI®(decitabine and cedazuridine) | New Drug Approval | 7/7/2020 | View PDF | ||||
| Rukobia™ (fostemsavir) | New Drug Approval | 7/2/2020 | View PDF | ||||
| RUKOBIA (fostemsavir) | New Drug Approval | 7/2/2020 | View PDF | ||||
| Tralement™ (trace elements injection 4) | Clinical Update | 7/2/2020 | View PDF | ||||
| Suprep® Bowel Prep Kit (sodium sulfate, potassium sulfate, magnesium sulfate) | First Time Generic Approval | 7/1/2020 | View PDF | ||||
| Stelara (ustekinumab) Injection | Clinical Update | 6/30/2020 | View PDF | ||||
| Bavencio (avelumab) Injection | Clinical Update | 6/30/2020 | View PDF | ||||
| Retacrit™ (epoetin alfa-epbx) | Clinical Update | 6/30/2020 | View PDF | ||||
| PHESGO™ (pertuzumab, trastuzumab, and hyaluronidase-zzxf) | New Drug Approval | 6/29/2020 | View PDF | ||||
| Keytruda (pembrolizumab) Injection | Clinical Update | 6/29/2020 | View PDF | ||||
| Keytruda (pembrolizumab) for Injection | Clinical Update | 6/29/2020 | View PDF | ||||
| MYCAPSSA®(octreotide) | Clinical Update | 6/26/2020 | View PDF | ||||
| FINTEPLA® (fenfluramine) | New Drug Approval | 6/25/2020 | View PDF | ||||
| Keytruda (pembrolizumab) Injection | Clinical Update | 6/24/2020 | View PDF | ||||
| XPOVIO® (selinexor) | New Drug Approval | 6/22/2020 | View PDF | ||||
| Xpovio(Selinexor) Tablets | Clinical Update | 6/22/2020 | View PDF | ||||
| Tazveik™ (tazemetostat) | New Drug Approval | 6/19/2020 | View PDF | ||||
| Gimoti® (metoclopramide hydrochloride) | Clinical Update | 6/19/2020 | View PDF | ||||
| Tazverik (tazemetostat) Tablets | Clinical Update | 6/18/2020 | View PDF | ||||
| Crysvita (burosumab-twza) Injection | Clinical Update | 6/18/2020 | View PDF | ||||
| Dupixent (dipulumab) Injection | Clinical Update | 6/18/2020 | View PDF | ||||
| Cosentyx (secukinumab) Injection | Clinical Update | 6/16/2020 | View PDF | ||||
| Keytruda (pembrolizumab) for Injection | Clinical Update | 6/16/2020 | View PDF | ||||
| Ilaris (canakinumab) Injection | Clinical Update | 6/16/2020 | View PDF | ||||
| ZEPZELCA™ (lurbinectedin) | New Drug Approval | 6/15/2020 | View PDF | ||||
| LYUMJEV™ (insulin lispro) | New Drug Approval | 6/15/2020 | View PDF | ||||
| Gardasil 9 (human papillomavirus 9-valent vaccine, recombinant) Injection | Clinical Update | 6/12/2020 | View PDF | ||||
| Tivicay® and Tivicay® PD (dolutegravir) | Clinical Update | 6/12/2020 | View PDF | ||||
| TIVICAY PD (dolutegravir) | Clinical Update | 6/12/2020 | View PDF | ||||
| UPLIZNA™ (inebilizumab-cdon) | New Drug Approval | 6/11/2020 | View PDF | ||||
| Semglee™ (insulin glargine injection) | Clinical Update | 6/11/2020 | View PDF | ||||
| Opdivo (nivolumab) Injection | Clinical Update | 6/10/2020 | View PDF | ||||
| LifEMS Naloxone (naloxone hydrochloride) | Clinical Update | 6/8/2020 | View PDF | ||||
| Dojolvi™ (triheptanoin) | New Drug Approval | 6/6/2020 | View PDF | ||||
| Recarbrio (imipenem, cilastatin, and relebactam) for Injection | Clinical Update | 6/4/2020 | View PDF | ||||
| Xerava™ (eravacycline) | Clinical Update | 6/3/2020 | View PDF | ||||
| Vivlodex™ (meloxicam) | First Time Generic Approval | 6/1/2020 | View PDF | ||||
| ZILXI™ (minocycline) | New Drug Approval | 5/29/2020 | View PDF | ||||
| Tecentriq (atezolizumab) Injection | Clinical Update | 5/29/2020 | View PDF | ||||
| Taltz (ixekizumab) Injection | Clinical Update | 5/29/2020 | View PDF | ||||
| Cyramza (ramucirumab) Injection | Clinical Update | 5/29/2020 | View PDF | ||||
| Brilinta (ticagrelor) Tablets | Clinical Update | 5/28/2020 | View PDF | ||||
| Sirturo (bedaquiline) Tablets | Clinical Update | 5/27/2020 | View PDF | ||||
| Dupixent (dupilumab) Injection | Clinical Update | 5/26/2020 | View PDF | ||||
| VESIcare (solifenacin succinate) Tablets | Clinical Update | 5/26/2020 | View PDF | ||||
| Multiple | Formulary & Clinical Updates | 5/25/2020 | View PDF | ||||
| Alunbrig (brigatinib) Tablets | Clinical Update | 5/22/2020 | View PDF | ||||
| KYNMOBI™ (apomorphine hydrochloride) | New Drug Approval | 5/21/2020 | View PDF | ||||
| Vascepa® icosapent ethyl | First Time Generic Approval | 5/21/2020 | View PDF | ||||
| Samsca® Tablets (tolvaptan tablets) | First Time Generic Approval | 5/19/2020 | View PDF | ||||
| Lynparza (olaparib) Tablets | Clinical Update | 5/19/2020 | View PDF | ||||
| Ferriprox (deferiprone) Tablets and Oral Solution | Clinical Update | 5/19/2020 | View PDF | ||||
| Tecentriq (atezolizumab) Injection | Clinical Update | 5/18/2020 | View PDF | ||||
| Banzel® rufinamide | First Time Generic Approval | 5/16/2020 | View PDF | ||||
| Qinlock™ (ripretinib) | New Drug Approval | 5/15/2020 | View PDF | ||||
| Noxafil® Oral Suspension (posaconazole oral suspension) | First Time Generic Approval | 5/15/2020 | View PDF | ||||
| Opdivo (nivolumab) Injection | Clinical Update | 5/15/2020 | View PDF | ||||
| Rubraca (rucaparib) Tablets | Clinical Update | 5/15/2020 | View PDF | ||||
| Nexium® 24HR DelayedRelease Tablets (esomeprazole magnesium delayed-release) | First Time Generic Approval | 5/14/2020 | View PDF | ||||
| Symfi™, Symfi Lo™ (efavirenz-lamivu-tenofov disoproxil fumarate) | First Time Generic Approval | 5/14/2020 | View PDF | ||||
| Pomalyst (pomalidomide) Capsules | Clinical Update | 5/14/2020 | View PDF | ||||
| Taclonex® (calcipotriene and betamethasone dipropionate) | First Time Generic Approval | 5/11/2020 | View PDF | ||||
| Desonate® (desonide gel 0.05%) | First Time Generic Approval | 5/11/2020 | View PDF | ||||
| Retevmo™ (selpercatinib) | New Drug Approval | 5/8/2020 | View PDF | ||||
| Lynparza (olaparib) Tablets | Clinical Update | 5/8/2020 | View PDF | ||||
| Tabrecta™ (capmatinib) | New Drug Approval | 5/6/2020 | View PDF | ||||
| Farxiga (dapagliflozin) Tablets | Clinical Update | 5/5/2020 | View PDF | ||||
| Zejula (niraparib) Capsules | Clinical Update | 4/29/2020 | View PDF | ||||
| Jublia (efinaconazole) Topical Solution | Clinical Update | 4/26/2020 | View PDF | ||||
| Ongentys® (opicapone) | New Drug Approval | 4/24/2020 | View PDF | ||||
| Adrenalin® (epinephrine Injection USP) | First Time Generic Approval | 4/24/2020 | View PDF | ||||
| Ongentys® (opicapone) | Clinical Update | 4/24/2020 | View PDF | ||||
| Plaquenil (hydroxychloroquine; chloroquine) | Clinical Update | 4/24/2020 | View PDF | ||||
| Meningococcal (Groups A, C, Y, W) Conjugate Vaccine (MenQuadfi®) | Clinical Update | 4/23/2020 | View PDF | ||||
| Trodelvy™ (sacituzumab govitecan-hziy) | New Drug Approval | 4/22/2020 | View PDF | ||||
| Cloderm™ (clocortolone pivalate) | First Time Generic Approval | 4/21/2020 | View PDF | ||||
| Imbruvica (ibrutinib) Capsules and Tablets | Clinical Update | 4/21/2020 | View PDF | ||||
| Pemazyre™ (pemigatinib) | New Drug Approval | 4/17/2020 | View PDF | ||||
| Multiple | Formulary & Clinical Updates | 4/15/2020 | View PDF | ||||
| Butrans® (buprenorphine transdermal system) | First Time Generic Approval | 4/14/2020 | View PDF | ||||
| Koselugo™ (selumetinib) | New Drug Approval | 4/10/2020 | View PDF | ||||
| Braftovi (encorafenib) Capsules | Clinical Update | 4/8/2020 | View PDF | ||||
| Reblozyl (luspatercept-aamt) for Injection | Clinical Update | 4/3/2020 | View PDF | ||||
| Tukysa™ (tucatinib) | New Drug Approval | 4/1/2020 | View PDF | ||||
| Imfinzi (durvalumab) Injection | Clinical Update | 3/30/2020 | View PDF | ||||
| Triferic (ferric pyrophosphate citrate) | Clinical Update | 3/27/2020 | View PDF | ||||
| Taltz (ixekizumab) Injection | Clinical Update | 3/26/2020 | View PDF | ||||
| Zeposia® (ozanimod) | New Drug Approval | 3/25/2020 | View PDF | ||||
| Nexium® 10 mg OS (esomeprazole magnesium delayed-release for oral suspension, 10 mg) | First Time Generic Approval | 3/23/2020 | View PDF | ||||
| Nexium® 20 mg, 40 mg OS (esomeprazole magnesium) | First Time Generic Approval | 3/23/2020 | View PDF | ||||
| Eucrisa (crisaborole) Topical Ointment | Clinical Update | 3/23/2020 | View PDF | ||||
| Epclusa® (sofosbuvir and velpatasvir) | Clinical Update | 3/19/2020 | View PDF | ||||
| Pradaxa® (dabigatran etexilate) | First Time Generic Approval | 3/11/2020 | View PDF | ||||
| Isturisa® (osilodrostat) | New Drug Approval | 3/6/2020 | View PDF | ||||
| Evomela™ (melphalan) | First Time Generic Approval | 3/6/2020 | View PDF | ||||
| Tepadina® (thiotepa injection) | First Time Generic Approval | 3/4/2020 | View PDF | ||||
| Singulair (montelukast) | Clinical Update | 3/4/2020 | View PDF | ||||
| Riomet® (metformin hydrochloride) | First Time Generic Approval | 3/3/2020 | View PDF | ||||
| Sarclisa® (isatuximab-irfc) | New Drug Approval | 3/2/2020 | View PDF | ||||
| Migranal® (dihydroergotamine mesylate) | First Time Generic Approval | 2/28/2020 | View PDF | ||||
| Nurtec™ ODT (rimegepant) | New Drug Approval | 2/27/2020 | View PDF | ||||
| Barhesys® (amisulpride) | New Drug Approval | 2/26/2020 | View PDF | ||||
| Daraprim® (pyrimethamine) | First Time Generic Approval | 2/26/2020 | View PDF | ||||
| ProAir® HFA (albuterol sulfate inhalation aeroso) | First Time Generic Approval | 2/24/2020 | View PDF | ||||
| Vyepti™ (eptinezumab-jjmr) | New Drug Approval | 2/21/2020 | View PDF | ||||
| Nexletol™ (bempedoic acid) | New Drug Approval | 2/21/2020 | View PDF | ||||
| Vimovo® (naproxen and esomeprazole magnesium tablets) | First Time Generic Approval | 2/18/2020 | View PDF | ||||
| TWIRLA® (levonorgestrel and ethinylestradiol) | New Drug Approval | 2/14/2020 | View PDF | ||||
| Belviq; Belviq XR (lorcaserin) | Clinical Update | 2/13/2020 | View PDF | ||||
| Proventil® HFA (albuterol sulfate inhalation aerosol 90 mcg, (base)/actuation) | First Time Generic Approval | 2/8/2020 | View PDF | ||||
| Multiple | Formulary & Clinical Updates | 2/2/2020 | View PDF | ||||
| Hicon® (sodium Iodide I 131 Solution USP and Sodium Iodide I 131 Capsules USP) | First Time Generic Approval | 2/2/2020 | View PDF | ||||
| BYNFEZIA™ (octreotide acetate) | New Drug Approval | 1/28/2020 | View PDF | ||||
| Clozaril (clozapine) | Clinical Update | 1/28/2020 | View PDF | ||||
| Dificid® (fidaxomicin) | Clinical Update | 1/24/2020 | View PDF | ||||
| Tepezza™ (teprotumumab-trbw) | New Drug Approval | 1/21/2020 | View PDF | ||||
| Zohydro® ER (hydrocodone bitartrate ER capsule) | First Time Generic Approval | 1/21/2020 | View PDF | ||||
| Monoferric® (ferric derisomaltose) | New Drug Approval | 1/16/2020 | View PDF | ||||
| Ozempic® (semaglutide) | Clinical Update | 1/16/2020 | View PDF | ||||
| Ayvakit™ (avapritinib) | New Drug Approval | 1/9/2020 | View PDF | ||||
| Conjupri™ (levamlodipine) | New Drug Approval | 12/19/2019 | View PDF | ||||
| RediTrex® (methotrexate) | Clinical Update | 11/27/2019 | View PDF | ||||
| Exservan™ (riluzole) | Clinical Update | 11/22/2019 | View PDF | ||||
| Hemady™ (dexamethasone) | Clinical Update | 10/3/2019 | View PDF | ||||
| fesoterodine fumarate (fesoterodine fumarate) | First Time Generic Approval | 9/13/2019 | View PDF | ||||
| Ibsrela® (tenapanor) | New Drug Approval | 9/12/2019 | View PDF | ||||
| ORTIKOS® (budesonide) | Clinical Update | 6/13/2019 | View PDF | ||||
| Polivy™ (polatuzumab vedotin-piiq) | Clinical Update | 6/10/2019 | View PDF | ||||
| mupirocin/lidocaine | Clinical Update | 5/15/2019 | View PDF | ||||
| Kuvan® (sapropterin dihydrochloride) | First Time Generic Approval | 5/10/2019 | View PDF | ||||
| Ferriprox® (deferiprone) | First Time Generic Approval | 2/8/2019 | View PDF | ||||
| Atripla® (efavirenz-emtricitabin-tenofovir disoproxil fumarate) | First Time Generic Approval | 11/9/2018 | View PDF | ||||
| Abiraterone (abiraterone) | Clinical Update | 10/31/2018 | View PDF | ||||
| Aubagio® (teriflunomide ) | First Time Generic Approval | 9/4/2018 | View PDF | ||||
| Truvada® (emtricitabine-tenofovir disoproxil fumarate) | Clinical Update | 8/22/2018 | View PDF | ||||
| Emtriva® (emtricitabine) | First Time Generic Approval | 7/2/2018 | View PDF | ||||
| Truvada® (emtricitabine-tenofovir) | First Time Generic Approval | 6/8/2017 | View PDF | ||||
| Dexilant™ (dexlansoprazole) | First Time Generic Approval | 4/19/2017 | View PDF | ||||
| Amjevita® (adalimumab-atto) | New Drug Approval | 9/23/2016 | View PDF | ||||
| Ofirmev®(acetaminophen) | First Time Generic Approval | 6/13/2016 | View PDF | ||||
| Fabior™ (tazarotene) | Clinical Update | 5/11/2012 | View PDF | ||||
| MoviPrep (Peg-3550, sodium sulfate, NaCl, KCL, sodium ascorbate and ascorbic acid) | First Time Generic Approval | 1/25/2012 | View PDF |
